NCT01571323View on ClinicalTrials.gov

Combined Use of Oxytocin and Misoprostol Versus Oxytocin Infusion and Misoprostol Alone to Reduce Blood Loss at Cesarean Section

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

September 30, 2012

Conditions
Post Partum Haemorrhage
Interventions
DRUG

Misoprostol

The misoprostol group (groupM) received 400 µg sublingually and infusion of lactated Ringer ( which one ampoule placebo dissolved it)

DRUG

Oxytocin

The oxytocin group(group O) received intravenous infusion of 20 units of oxytocin soon after delivery of the neonate and one tablet of placebo sublingually. (20 IU syntocinon dissolved in 1liter of lactated Ringer's solution) at the rate of 1000 ml over a 1h period, immediately after delivery of the neonate

DRUG

Oxytocin and Misoprostol

The combined misoprostol-oxytocin group(group MO) received 200 µg and 5 iu oxytocin bolus intravenously immediately after delivery of the neonate .

Trial Locations (1)

3419759811

Qazvin Medical University Science, Qazvin

All Listed Sponsors
lead

Qazvin University Of Medical Sciences

OTHER

NCT01571323 - Combined Use of Oxytocin and Misoprostol Versus Oxytocin Infusion and Misoprostol Alone to Reduce Blood Loss at Cesarean Section | Biotech Hunter | Biotech Hunter